Financials
Financial year 2026
Pharmanovia Belgium from Brasschaat, company number BE0837708529, closed financial year 2026 with a result of € 10,393 after tax. Compared with financial year 2025, the result moved from € 14,557 to € 10,393. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 24, 2026.
€ 36.7 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 10,393
▼ 29% vs 2025
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2026. Retained profit grew to € 32.1 million.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 3,783
▼ 31% vs 2025
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Profit after taxes | € 12,025 | € 12,831 | € 14,557 | € 10,393 | ▼ 29% |
| Equity | € 36,612,866 | € 36,625,698 | € 36,640,254 | € 36,650,648 | |
| Total debts | € 30,698 | € 41,538 | € 51,600 | € 66,810 | ▲ 29% |
| Retained profit | € 32,094,266 | € 32,107,098 | € 32,121,654 | € 32,132,048 | |
| Balance sheet total | € 36,643,564 | € 36,667,236 | € 36,691,854 | € 36,717,458 |
Key figures of Pharmanovia Belgium, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to Pharmanovia Belgium?
What happened at Pharmanovia Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 10,393 (▼ 29% vs 2025). Source: NBB ↗
- Mohammad Samy became a director. NBB
- Twan Nouwen became a director. NBB
- New establishment in Brasschaat. KBO
- Start of the company according to the CBE. KBO
In short
From € 12,025 profit in 2023 to € 10,393 profit in 2026.
Paid € 17,854 in corporate taxes since 2023.
Best year ever: 2025, with € 14,557 profit.
Management
Behind Pharmanovia Belgium are Justus Van Diemen, Mohammad Samy and Twan Nouwen. The shares are held by Atnahs Pharma UK Limited (100%). It owns 100% of Pharmanovia Benelux itself.
Directors
According to the 2026 annual accounts
Justus Van Diemen
Director
Mohammad Samy
Director
since 2026
Twan Nouwen
Director
since 2026
Shareholders
Atnahs Pharma UK Limited
100%
Participations
Pharmanovia Benelux
100%
Establishments
Establishment units
Physical locations of this company
Miksebaan 307
2930 Brasschaat
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0837.708.529
- VAT number
- BE 0837.708.529
- Registered office
- Miksebaan 307, 2930 Brasschaat
- Names & denominations
- Pharmanovia Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 December 2000
- Peppol
- Active · Active since 23 Apr 2026